611 related articles for article (PubMed ID: 19368505)
1. Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation.
Cordonnier C; Labopin M; Chesnel V; Ribaud P; De La Camara R; Martino R; Ullmann AJ; Parkkali T; Locasciulli A; Yakouben K; Pauksens K; Einsele H; Niederwieser D; Apperley J; Ljungman P;
Clin Infect Dis; 2009 May; 48(10):1392-401. PubMed ID: 19368505
[TBL] [Abstract][Full Text] [Related]
2. Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate vaccine in allogeneic stem cell transplant recipients: results from the EBMT IDWP01 trial.
Cordonnier C; Labopin M; Chesnel V; Ribaud P; Camara Rde L; Martino R; Ullmann AJ; Parkkali T; Locasciulli A; Yakouben K; Pauksens K; Bonnet E; Einsele H; Niederwieser D; Apperley J; Ljungman P
Vaccine; 2010 Mar; 28(15):2730-4. PubMed ID: 20117269
[TBL] [Abstract][Full Text] [Related]
3. Safety and immunogenicity of the American Academy of Pediatrics--recommended sequential pneumococcal conjugate and polysaccharide vaccine schedule in pediatric solid organ transplant recipients.
Lin PL; Michaels MG; Green M; Mazariegos GV; Webber SA; Lawrence KS; Iurlano K; Greenberg DP
Pediatrics; 2005 Jul; 116(1):160-7. PubMed ID: 15995047
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and reactogenicity of pneumococcal polysaccharide and conjugate vaccines in alaska native adults 55-70 years of age.
Miernyk KM; Butler JC; Bulkow LR; Singleton RJ; Hennessy TW; Dentinger CM; Peters HV; Knutsen B; Hickel J; Parkinson AJ
Clin Infect Dis; 2009 Jul; 49(2):241-8. PubMed ID: 19522655
[TBL] [Abstract][Full Text] [Related]
5. Protective antibody responses to pneumococcal conjugate vaccine after autologous hematopoietic stem cell transplantation.
Antin JH; Guinan EC; Avigan D; Soiffer RJ; Joyce RM; Martin VJ; Molrine DC
Biol Blood Marrow Transplant; 2005 Mar; 11(3):213-22. PubMed ID: 15744240
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.
Vesikari T; Wysocki J; Chevallier B; Karvonen A; Czajka H; Arsène JP; Lommel P; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S66-76. PubMed ID: 19325449
[TBL] [Abstract][Full Text] [Related]
7. Relationship between IgG titers and opsonocytophagocytic activity of anti-pneumococcal antibodies after immunization with the 7-valent conjugate vaccine in allogeneic stem cell transplant.
Cordonnier C; Labopin M; Jansen KU; Pride M; Chesnel V; Bonnet E; Einsele H; Ljungman P;
Bone Marrow Transplant; 2010 Sep; 45(9):1423-6. PubMed ID: 20023707
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and safety of a pneumococcal conjugate 7-valent vaccine in infants with sickle cell disease.
Reinert P; Benkerrou M; de Montalembert M; Lesprit E; Abadie I; Bernaudin F; Doit C; Bingen E; Tetelboum R; Bonnet E
Pediatr Infect Dis J; 2007 Dec; 26(12):1105-9. PubMed ID: 18043446
[TBL] [Abstract][Full Text] [Related]
9. Randomised revaccination with pneumococcal polysaccharide or conjugate vaccine in asplenic children previously vaccinated with polysaccharide vaccine.
Smets F; Bourgois A; Vermylen C; Brichard B; Slacmuylders P; Leyman S; Sokal E
Vaccine; 2007 Jul; 25(29):5278-82. PubMed ID: 17576024
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and safety of measles-mumps-rubella, varicella and Haemophilus influenzae type b vaccines administered concurrently with a fourth dose of heptavalent pneumococcal conjugate vaccine compared with the vaccines administered without heptavalent pneumococcal conjugate vaccine.
Black SB; Cimino CO; Hansen J; Lewis E; Ray P; Corsaro B; Graepel J; Laufer D
Pediatr Infect Dis J; 2006 Apr; 25(4):306-11. PubMed ID: 16567981
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind trial of pneumococcal vaccination in adult allogeneic stem cell transplant donors and recipients.
Kumar D; Chen MH; Welsh B; Siegal D; Cobos I; Messner HA; Lipton J; Humar A
Clin Infect Dis; 2007 Dec; 45(12):1576-82. PubMed ID: 18190318
[TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine.
Bryant KA; Block SL; Baker SA; Gruber WC; Scott DA;
Pediatrics; 2010 May; 125(5):866-75. PubMed ID: 20435707
[TBL] [Abstract][Full Text] [Related]
13. Response to conjugate pneumococcal and Haemophilus influenzae type b vaccines in asplenic patients.
Meerveld-Eggink A; de Weerdt O; van Velzen-Blad H; Biesma DH; Rijkers GT
Vaccine; 2011 Jan; 29(4):675-80. PubMed ID: 21115060
[TBL] [Abstract][Full Text] [Related]
14. Antibody response to polysaccharide conjugate vaccines after nonmyeloablative allogeneic stem cell transplantation.
Meerveld-Eggink A; van der Velden AM; Ossenkoppele GJ; van de Loosdrecht AA; Biesma DH; Rijkers GT
Biol Blood Marrow Transplant; 2009 Dec; 15(12):1523-30. PubMed ID: 19896075
[TBL] [Abstract][Full Text] [Related]
15. Nasopharyngeal pneumococcal carriage after combined pneumococcal conjugate and polysaccharide vaccination in children with a history of recurrent acute otitis media.
Veenhoven RH; Bogaert D; Schilder AG; Rijkers GT; Uiterwaal CS; Kiezebrink HH; van Kempen MJ; Dhooge IJ; Bruin J; Ijzerman EP; de Groot R; Kuis W; Hermans PW; Sanders EA
Clin Infect Dis; 2004 Oct; 39(7):911-9. PubMed ID: 15472839
[TBL] [Abstract][Full Text] [Related]
16. Immunological responses to pneumococcal vaccine in frail older people.
Ridda I; Macintyre CR; Lindley R; Gao Z; Sullivan JS; Yuan FF; McIntyre PB
Vaccine; 2009 Mar; 27(10):1628-36. PubMed ID: 19100304
[TBL] [Abstract][Full Text] [Related]
17. The pneumococcal conjugate vaccine.
Jacobson RM; Poland GA
Minerva Pediatr; 2002 Aug; 54(4):295-303. PubMed ID: 12131865
[TBL] [Abstract][Full Text] [Related]
18. A randomized study comparing combined pneumococcal conjugate and polysaccharide vaccination schedules in adults.
Lazarus R; Clutterbuck E; Yu LM; Bowman J; Bateman EA; Diggle L; Angus B; Peto TE; Beverley PC; Mant D; Pollard AJ
Clin Infect Dis; 2011 Mar; 52(6):736-42. PubMed ID: 21367726
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity, reactogenicity, and safety of a seven-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a fully liquid DTPa-IPV-HBV-Hib combination vaccine in healthy infants.
Olivier C; Belohradsky BH; Stojanov S; Bonnet E; Petersen G; Liese JG
Vaccine; 2008 Jun; 26(25):3142-52. PubMed ID: 18502545
[TBL] [Abstract][Full Text] [Related]
20. IgG antibody concentrations after immunization with 11-valent mixed-carrier pneumococcal conjugate vaccine in efficacy trial against pneumonia among Filipino infants.
Soininen A; Nohynek H; Lucero M; Jousimies K; Ugpo J; Williams G; Käyhty H;
Vaccine; 2009 May; 27(20):2680-8. PubMed ID: 19428879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]